<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred-twenty aged patients with kidney deficiency syndrome of ischemic cardio-cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> were treated with Epimedium compound granules </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that after therapeutic period the total and marked effective rates were 96.7%, 39.5% respectively in treatment group </plain></SENT>
<SENT sid="2" pm="."><plain>The rates of improvement were 70% in electrocardiogram of the patients with <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart diseases</z:e>, and 75% in electro-encephalogram of the patients with cerebral arterosclerosis </plain></SENT>
<SENT sid="3" pm="."><plain>The therapeutic effectiveness in treatment group was better than that in control group treated with Su-Guan-Bian </plain></SENT>
<SENT sid="4" pm="."><plain>According to experimental observation, the therapeutic effectiveness was related to the facts that Epimedium compound granules lower blood <z:chebi fb="23" ids="18059">lipid</z:chebi> have anti-free radicals and adjust balance between prostacyctin I2 and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi>(<z:chebi fb="0" ids="15627">TXA2</z:chebi>/<z:chebi fb="0" ids="15552">PGI2</z:chebi>) </plain></SENT>
</text></document>